Information  X 
Enter a valid email address

Glaxosmithkline PLC Ord 25P (GSK)

Date Time Source Announcement
02 Dec 2021 7:02 am
RNS
Sotrovimab retains its activity vs Omicron variant
01 Dec 2021 11:05 am
PRN
Total Voting Rights
24 Nov 2021 4:17 pm
RNS
Director/PDMR Shareholding
  4:00 pm
RNS
GSK publishes provisional 2022 dividend dates
23 Nov 2021 3:06 pm
RNS
Director/PDMR Shareholding
17 Nov 2021 7:00 am
RNS
Nucala approved in Europe for more indications
15 Nov 2021 4:37 pm
RNS
Block listing Interim Review
12 Nov 2021 12:00 pm
RNS
Phase III IM administration data for sotrovimab
  9:23 am
RNS
Director/PDMR Shareholding
10 Nov 2021 11:28 am
RNS
Director/PDMR Shareholding
05 Nov 2021 5:33 pm
RNS
GSK shares positive Phase III data for daprodustat
01 Nov 2021 5:11 pm
RNS
Total Voting Rights
27 Oct 2021 2:23 pm
RNS
Director/PDMR Shareholding
  12:00 pm
RNS
3rd Quarter Results
  9:00 am
RNS
Directorate Change
15 Oct 2021 2:41 pm
RNS
Director/PDMR Shareholding
14 Oct 2021 4:31 pm
RNS
Director/PDMR Shareholding
  4:28 pm
RNS
Director/PDMR Shareholding
13 Oct 2021 1:55 pm
RNS
Director/PDMR Shareholding
12 Oct 2021 3:17 pm
RNS
Director/PDMR Shareholding
  1:36 pm
RNS
Director/PDMR Shareholding
  1:33 pm
RNS
Director/PDMR Shareholding
  1:30 pm
RNS
Director/PDMR Shareholding
  1:28 pm
RNS
Director/PDMR Shareholding
01 Oct 2021 11:54 am
RNS
Total Voting Rights
24 Sep 2021 5:28 pm
RNS
Director/PDMR Shareholding
22 Sep 2021 3:58 pm
RNS
Director/PDMR Shareholding
20 Sep 2021 2:42 pm
RNS
Director Declaration
13 Sep 2021 5:26 pm
RNS
Director/PDMR Shareholding
09 Sep 2021 4:42 pm
RNS
Director/PDMR Shareholding
07 Sep 2021 4:54 pm
RNS
Director/PDMR Shareholding
03 Sep 2021 9:32 am
RNS
Director/PDMR Shareholding
01 Sep 2021 11:44 am
RNS
Total Voting Rights
31 Aug 2021 7:00 am
RNS
SK bio & GSK start Ph3 Covid-19 vaccine trial
25 Aug 2021 2:01 pm
RNS
Director/PDMR Shareholding
23 Aug 2021 4:39 pm
RNS
Director/PDMR Shareholding
13 Aug 2021 9:38 am
RNS
Director/PDMR Shareholding - amendment
11 Aug 2021 2:18 pm
RNS
Director/PDMR Shareholding
  12:34 pm
RNS
Director/PDMR Shareholding
05 Aug 2021 9:00 am
RNS
Block Listing Application
02 Aug 2021 2:23 pm
RNS
Total Voting Rights
28 Jul 2021 5:32 pm
RNS
Director/PDMR Shareholding
  12:00 pm
RNS
2nd Quarter Results
26 Jul 2021 4:59 pm
RNS
Director/PDMR Shareholding
23 Jul 2021 2:32 pm
RNS
Board Committee Changes
22 Jul 2021 2:45 pm
RNS
CEO Designate of new Consumer Healthcare company
16 Jul 2021 12:00 pm
RNS
GSK announces daprodustat phase 3 headline results
  10:24 am
RNS
Director/PDMR Shareholding
15 Jul 2021 1:21 pm
RNS
Director/PDMR Shareholding
14 Jul 2021 3:34 pm
RNS
Director/PDMR Shareholding
  3:17 pm
RNS
Director/PDMR Shareholding
13 Jul 2021 9:44 am
RNS
Director/PDMR Shareholding
  9:33 am
RNS
Director/PDMR Shareholding
12 Jul 2021 10:23 am
RNS
Director/PDMR Shareholding
  10:18 am
RNS
Director/PDMR Shareholding
09 Jul 2021 9:30 am
RNS
Director/PDMR Shareholding
02 Jul 2021 12:36 pm
RNS
GSK and Alector collaboration in immuno-neurology
  10:41 am
RNS
Elliott Advisors (UK) letter to GSK
01 Jul 2021 2:29 pm
RNS
Total Voting Rights
25 Jun 2021 4:54 pm
RNS
Director/PDMR Shareholding

a d v e r t i s e m e n t